Ex Parte PEYMAN - Page 4



              Appeal No. 2002-0783                                                                  Page 4                
              Application No. 09/268,957                                                                                  

              showing of good and sufficient reasons why they were not earlier presented."  In Paper                      
              No. 16, mailed February 13, 2003, the examiner determined that Exhibits A-E would not                       
              be admitted because applicant has not provided a showing of good and sufficient                             
              reasons why they were not earlier presented.  Accordingly, those exhibits are not part of                   
              the administrative record.                                                                                  
                     In other words, applicant's Reply Brief is technically of record.  But applicant's                   
              argument in the Reply Brief, with respect to the propriety of combining references, is                      
              unavailing because that argument is based on Exhibits A-E which are not of record.                          
              Cf., In re Mehta, 347 F.2d 859, 866, 146 USPQ 284, 289 (CCPA 1965) (Unsworn                                 
              "Exhibit" can be taken merely as argument and not to establish facts).                                      


                                                       The Merits                                                         
                     El-Rashidy discloses a composition comprising an osmotic agent; a swellable                          
              hydrophilic carrier; and a water dispersible polymer in combination with an effective                       
              amount of water soluble drug (active ingredient) for providing controlled release of the                    
              drug by sublingual route.  Additionally, El-Rashidy discloses a T90 value and a ratio of                    
              the amount by weight of osmotic agent to the amount by weight of swellable hydrophilic                      
              carrier which meet the terms of claim 1 on appeal.                                                          
                     El-Rashidy discloses a composition for the controlled release of water soluble                       
              drugs by sublingual mode of administration, focusing attention on the specific drug                         
              apomorphine hydrochloride.  As best seen in Example 19, El-Rashidy discloses                                
              apomorphine hydrochloride for treating male erectile dysfunction.  According to El-                         






Page:  Previous  1  2  3  4  5  6  7  8  9  10  Next 

Last modified: November 3, 2007